PM8002 Clinical Trials

2 actively recruiting trials

▼ -1 trial since June 2026

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

Biotheus Inc.2

Indications

Cancer2
Malignant Neoplasm1
Triple Negative Breast Cancer (TNBC)1
Breast Cancer1

Other2 trials

PM8002 in the Treatment of Patients With Advanced Solid Tumors

Phase 1/2

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.